Bilateral anterior uveitis secondary to erlotinib
We would like to report the first case of bilateral severe anterior uveitis secondary to erlotinib. Erlotinib is an epidermal growth factor receptor (EGFR) inhibitor which can contain certain cancer cells [1]. It is licensed for use in patients with non-small-cell lung carcinoma (NSCLC) in the UK as...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | E-Article |
| Language: | English |
| Published: |
Springer-Verlag
2010
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/22023/1/Bilateral%20anterior%20uveitis%20secondary%20to%20erlotinib%20%28abstract%29.pdf http://ir.unimas.my/id/eprint/22023/ https://link.springer.com/article/10.1007/s00228-010-0873-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|